Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD)

CompletedOBSERVATIONAL
Enrollment

2,370

Participants

Timeline

Start Date

January 31, 2009

Study Completion Date

December 31, 2009

Conditions
RefluxHeartburnRegurgitationEsophagitis
Trial Locations (66)

Unknown

Research Site, Amstetten

Research Site, Baden

Research Site, Bludenz

Research Site, Bregenz

Research Site, Feldbach

Research Site, Gmunden

Research Site, Graz

Research Site, Groß-Gerungs

Research Site, Innsbruck

Research Site, Kitzbühel

Research Site, Klagenfurt

Research Site, Krems

Research Site, Kufstein

Research Site, Leibnitz, Styria

Research Site, Leoben

Research Site, Linz

Research Site, Mattersburg

Research Site, Mistelbach

Research Site, Mürzzuschlag

Research Site, Neunkirchen

Research Site, Neusiedl

Research Site, Perg

Research Site, Sankt Veit im Pongau

Research Site, Schwaz

Research Site, Steyr

Research Site, Villach

Research Site, Vöcklabruck

Research Site, Völkermarkt

Research Site, Wels

Research Site, Zell

Research Site, Brescia

Research Site, Arendal

Research Site, Ålesund

Research Site, Bergen

Research Site, Bodø

Research Site, Haugesund

Research Site, Kristiansund

Research Site, Levanger

Research Site, Molde

Research Site, Mosjøen

Research Site, Orkdal

Research Site, Oslo

Research Site, Tynset

Research Site, Valencia

Research Site, Arlöv

Research Site, Dalby

Research Site, Falköping

Research Site, Farsta

Research Site, Gothenburg

Research Site, Helsingborg

Research Site, Karlshamn

Research Site, Kristianstad

Research Site, Kungsängen

Research Site, Luleå

Research Site, Lund

Research Site, Malmo

Research Site, Munkedal

Research Site, Nordstan(Goteborg)

Research Site, Partille

Research Site, Piteå

Research Site, Skanör

Research Site, Solna

Research Site, Södertälje

Research Site, Stockholm

Research Site, Trollhättan

Research Site, Vännäs

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY